Invitrogen™ Human DNMT3A ELISA Kit

Ref.: BL-RE-159539Manufacturer ref.: EH157RBX5 5 x 96 tests
€2,950.00 excl. VAT

Human DNMT3A quantitates human DNMT3A in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human DNMT3A.

Accession number
Au015806 ; ADN (cytosine-5-)-méthyltransférase 3 alpha ; ADN (cytosine-5)-méthyltransférase 3 A ; ADN cytosine méthyltransférase 3A2 ; ADN méthyltransférase 3 alpha ; ADN méthyltransférase 3 A ; ADN méthyltransférase HsaIIIA ; ADN méthyltransférase MIIIA ; ADN méthyltransférase MIIIA ; ADN MsaIIIA MsaIIIA MmuIIIA ; ADN MmuIIIA DNMT3A ; DNMT3A2 ; M.HsaIIIA ; MmuIIIA ; TBRS ; W91664
Dose range
1.4 to 300 ng/mL
Sensitivity of the dosage
1.4 ng/mL
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human DNMT3A quantitates human DNMT3A in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human DNMT3A.

Human DNMT3A quantitates human DNMT3A in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human DNMT3A.

Methylation of the DNA to cytosine residues plays an important role in regulating genetic expression, genomic printing and is essential for mammalian development. The hypermethylation of CpG islands in tumour suppressor genes or the hypomethylation of bulk genomics DNA may be related to the development of cancer. To date, 3 families of mammalian methyltransferase d-DNA genes have been identified, including DNMT1, DNMT2, and DNMT3. DNMT1 is expressed constitutively in cell proliferation and inactivation of this gene causes overall demethylation of genomic DNA and embryo lethality. DNMT2 is expressed at low levels in adult tissues and its inactivation does not affect the methylation of the DNA or the maintenance of methylation. Members of the DNMT3, DNMT3a, and DNMT3b family are strongly expressed in ES cells, but their expression is regulated by ES cell differentiation and low in adult somatic tissues. Recently, natural mutations of the DNMT3b gene have been shown to occur in patients with rare autosomal recessive disorder called ICF (immunodeficiency, centromeric instability and facial abnormalities).

Sensitivity

Sensitivity of dosage: 1.4 ng/mL.

Measurement range

Dose range: 1.4 to 300 ng/mL.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: DNMT3A.

Samples

Type of sample: Plasma, Serum, Surnatant (plasma volume, 50 µl; Serum, 50 µl; Supernatant, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17134909
Specifications
Accession numberAu015806; DNA (cytosine-5-)-methyltransferase 3 alpha; DNA (cytosine-5)-methyltransferase 3 A; DNA cytosine methyltransferase 3A2; DNA methyltransferase 3 alpha; DNA methyltransferase 3 A; DNA methyltransferase HsaIIIA; DNA methyltransferase MIIIA; DNA methyltransferase MIIIA; DNA MsaIIIA M
Dose range1.4 to 300 ng/mL
Sensitivity of the dosage1.4 ng/mL
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q9Y6K1
Gene symbol(s)DNMT3A
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kitsPre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetDNMT3A
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 50 µl; Serum, 50 µl; Supernatant, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH157RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.